ArticleJournal of asthma and allergy2022

Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study.

Takanori Numata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.